Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeremy L. Baryza is active.

Publication


Featured researches published by Jeremy L. Baryza.


Archive | 2001

Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents

Andreas Stolle; Jacques Dumas; William Carley; Phillip D. G. Coish; Steven Magnuson; Yamin Wang; Dhanapalan Nagarathnam; Derek Lowe; Ning Su; William H. Bullock; Ann-Marie Campbell; Ning Qi; Jeremy L. Baryza; James H. Cook


Archive | 2002

4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

Gaetan Ladouceur; Emil Velthuisen; Soongyu Choi; Zhonghua Zhang; Yamin Wang; Jeremy L. Baryza; Philip Coish; Roger A. Smith; Jinshan Chen


Archive | 2001

17-Beta-hydroxysteroid dehydrogenase-II inhibitors

Jill E. Wood; Jeremy L. Baryza; Catherine Brennan; Soongyu Choi; James H. Cook; Brian R. Dixon; Paul Ehrlich; David Gunn; Ian McAlexander; Derek Lowe; Aniko Redman; William J. Scott; Yamin Wang


Bioorganic & Medicinal Chemistry Letters | 2005

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 2. SAR

David Gunn; Christiana Akuche; Jeremy L. Baryza; Marie-Louise Blue; Catherine Brennan; Ann-Marie Campbell; Soongyu Choi; James Cook; Patricia Conrad; Brian Dixon; Jacques Dumas; Paul Ehrlich; Todd Gane; Ted Joe; Jeffrey Johnson; Jerold Jordan; Richard Kramss; Peying Liu; Joan Levy; Derek Lowe; Ian McAlexander; Reina Natero; Anikó M. Redman; William Scott; Thomas Seng; Robert Sibley; Ming Wang; Yamin Wang; Jill Wood; Zhonghua Zhang


Archive | 2002

Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor

Gaetan Ladouceur; Emil Velthuisen; Soongyou Choi; Yamin Wang; Jeremy L. Baryza; Philip Coish; James H. Cook


Archive | 1998

Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists

Gaetan Ladouceur; Richard D. Connell; Jeremy L. Baryza; Ann-Marie Campbell; Timothy G. Lease; James H. Cook


Archive | 2003

Compounds useful for preparation of Beta-3 adrenoreceptor agonist

Gaetan Ladouceur; Richard D. Connell; Jeremy L. Baryza; Anne-marie Campbell; Timothy G. Lease; James H. Cook


Archive | 2004

PYRAZOLE DERIVATIVES FOR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR

Gaetan Ladouceur; Emil Velthuisen; Soongyu Choi; Yamin Wang; Jeremy L. Baryza; Phillip D. G. Coish; William H. Bullock; Roger A. Smith; Jinshan Chen


Archive | 2002

Composes derives de 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyle destines au traitement des maladies associees au recepteur 5-ht2c

Gaetan Ladouceur; Emil Velthuisen; Soongyu Choi; Zhonghua Zhang; Yamin Wang; Jeremy L. Baryza; Philip Coish; Roger A. Smith; Jinshan Chen


Archive | 2001

Indoles substituees, compositions pharmaceutiques contenant ces indoles et leur utilisation comme agent de fixation de ppar-

Andreas Stolle; Jacques Dumas; William Carley; Phillip D. G. Coish; Steven Magnuson; Yamin Wang; Dhanapalan Nagarathnam; Derek Lowe; Ning Su; William H. Bullock; Ann-Marie Campbell; Ning Qi; Jeremy L. Baryza; James H. Cook

Collaboration


Dive into the Jeremy L. Baryza's collaboration.

Top Co-Authors

Avatar

Soongyu Choi

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Derek Lowe

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge